Comorbidities, medication use, and overall survival in eight cancers: a multinational cohort study of 1.7 million patients across Europe
The European Health Data & Evidence Network has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806968. The JU receives support from the European Union's Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations partners.
Authors
- Carlos Míguez Sánchez (ORCID: https://orcid.org/0000-0002-3151-8860)
- K Verhamme
- Danielle Newby (ORCID: https://orcid.org/0000-0002-3001-1478)
- Miguel Ángel Mayer (ORCID: https://orcid.org/0000-0003-0362-6298)
- Agustina. Giuliodori
- Mahéva Vallet (ORCID: https://orcid.org/0000-0001-7007-0782)
- E. Fournier (ORCID: https://orcid.org/0000-0001-6717-8020)
- Ian Koblbauer
- Xihang Chen (ORCID: https://orcid.org/0009-0001-8112-8959)
- Peter Prinsen (ORCID: https://orcid.org/0000-0002-0444-4579)
- Asieh Golozar (ORCID: https://orcid.org/0000-0002-4243-155X)
- Andrea Pistillo (ORCID: https://orcid.org/0000-0002-4467-0220)
- Espen Enerly (ORCID: https://orcid.org/0000-0002-2974-2273)
- Irene López-Sánchez (ORCID: https://orcid.org/0009-0001-5658-8945)
- A. P. L. Robinson
- Jamie Elvidge (ORCID: https://orcid.org/0000-0002-6154-8091)
- Marek Oja (ORCID: https://orcid.org/0000-0002-3650-8194)
- Talita Duarte‐Salles (ORCID: https://orcid.org/0000-0002-8274-0357)
- Ravinder Claire (ORCID: https://orcid.org/0000-0001-8039-6161)
- A Delmestri
- Marta Alcalde-Herraiz
- George Corby (ORCID: https://orcid.org/0000-0002-5057-2985)
- Laura Pérez-Crespo
- P Hall
- Raivo Kolde (ORCID: https://orcid.org/0000-0003-2886-6298)
- Nicola Symmers
- Anna Palomar-Cros
- Wai Yi Man
- Alberto Moreno Conde
- Jelle Evers
- Eric Fey
- Martí Català
- James Koh
- Tiago Taveira-Gomes
- Jesus Moreno Conde
- Mees Mosseveld
- Colin McLean
- Fernanda Estevinho
- Jeremy Dietz
- Maria T. Sanchez-Santos
- Angela Leis
- Rafael Marcos-Gragera
- Edward Burn
- Juan Manuel Ramirez-Anguita
Institutions
- University of Geneva (CH)
- Universitat Autònoma de Barcelona (ES)
- Norwegian Institute of Public Health (NO)
- University of Helsinki (FI)
- Fernando Pessoa University (PT)
- Universidade do Porto (PT)
- Catalan Institute for Water Research (ES)
- Helsinki University Hospital (FI)
- Nuffield Orthopaedic Centre (GB)
- Erasmus MC (NL)
- Edinburgh Cancer Research (GB)
- National Institute for Health and Care Excellence (GB)
- University of Oxford (GB)
- Hospital Universitario Virgen Macarena (ES)
- HealthSim (United States) (US)
- Hospital Pedro Hispano (PT)
- Administração Regional de Saúde de Lisboa e Vale do Tejo (PT)
- Institut d'Investigació Biomèdica de Girona (ES)
- Institut Universitari d'Investigació en Atenció Primària Jordi Gol (ES)
- Cancer Registry of Norway (NO)
- Hospital Del Mar (ES)
- Instituto de Biomedicina de Sevilla (ES)
- Netherlands Comprehensive Cancer Organisation (NL)
- University of Tartu (EE)
Publication Details
- Journal
- The Lancet Regional Health - Europe
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1016/j.lanepe.2025.101585
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Univerzita Karlova v Praze
- National Institute for Health and Care Excellence
- European Federation of Pharmaceutical Industries and Associations
- European Commission
- Universitat de Barcelona
- Universitat Autònoma de Barcelona
- Sjællands Universitetshospital
- lékařská fakulta Univerzity Karlovy
- Norwegian Institute of Public Health